Figure 3.
Rationale of the designed compounds based on the pharmacophore model of VEGFR-2 inhibitors and using sunitinib as a lead compound.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.